All News and Events

25 March 2026

Event jointly organized by: AVE and St Vincent's Institute of Medical Research

6 January 2026

Please join us for a special Fireside chat on January 6th, 2026

21 May 2025

Event jointly organized by : Institute for Bioengineering of Catalunya (IBEC) and Centre for Genomic Regulation (CRG)

20 January 2026

Professor Yang Jianrong, a researcher and professor at with Sun Yat-sen University in Guangzhou, China, is a confirmed speaker at the upcoming Ninth Annual Mutational Scanning Symposium, March 25-27, in Melbourne, Australia.

10 November 2025

We aim to strike a balance between theoretical, computational, and experimental approaches to ensure comprehensive coverage of the field.

30 October 2025

An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify those with a genetic risk for elevated “bad” cholesterol—a major contributor to heart disease. Published in Science on Oct. 30, 2025, this resource can assist clinicians in predicting patient risk for heart attacks, allowing time for prevention and early treatment. 

17 December 2025

How can we use genomic technologies to tackle blood diseases? In this episode, we explain the role of genetic variants in blood disorders and how genomics approaches, such as gene editing can help cure these diseases.

Transcript and show notes can be found here.

30 June 2025

Who do you ask if you have a question about a gene? In this episode, we dive into the teams and scientists that are building an encyclopedia of knowledge about your genes.

Transcript and show notes can be found here.

23 March 2025

We can predict the weather, but can we predict genetic diseases from your genome?

In this episode we explain the challenges and the promises of variant effect predictors (VEPs)

with experts Dr Debbie Marks and Dr Joe Marsh

6 January 2026

Matthew Hurles is Director of the Wellcome Sanger Institute and leads a research group focused on deciphering the genetic causes of severe developmental disorders, and understanding how DNA mutates as it is passed from generation to generation.

3 February 2026

Yuriy is an Assistant Professor working at the intersection of immunology, genetics and genomics. His group at CCHMC builds new approaches to unlock the mysteries of inflammatory and autoimmune diseases. The research is a mixture of experimental and computational work that generates and analyzes large-scale genomic datasets. Yuriy obtained his PhD at the University of Toronto in the Department of Immunology and completed his postdoctoral training at Brigham and Women’s Hospital in affiliation with Harvard Medical School and the Broad...moreInstitute.

3 February 2026

Stephan Riesenberg is a German biochemist and genome engineer known for developing practical solutions to some of the most persistent limitations of CRISPR-based technologies. He is a Group Leader at the Max Planck Institute for Evolutionary Anthropology in Leipzig, where he develops molecular strategies to control DNA repair outcomes and enable predictable genome modification for research and biomedical applications. He earned his PhD in Biochemistry and later completed an MD-scientist degree at the University of Leipzig. Riesenberg was trained in...moreStephan Riesenberg is a German biochemist and genome engineer known for developing practical solutions to some of the most persistent limitations of CRISPR-based technologies. He is a Group Leader at the Max Planck Institute for Evolutionary Anthropology in Leipzig, where he develops molecular strategies to control DNA repair outcomes and enable predictable genome modification for research and biomedical applications. He earned his PhD in Biochemistry and later completed an MD-scientist degree at the University of Leipzig. Riesenberg was trained in two Nobel Prize-winning labs. He spent several years at the Max Planck Institute for Evolutionary Anthropology in the lab of Svante Pääbo, awarded the Nobel Prize in Physiology or Medicine in 2022, where he worked at the interface of genome engineering, human evolution, and functional genomics. Earlier, he trained at the University of Copenhagen in the lab of Morten Meldal, recipient of the 2022 Nobel Prize in Chemistry, gaining a strong foundation in chemical biology and protein chemistry. This combination of genetics and chemistry continues to define his technology-driven approach to biology.